Burrows Scott L Insider Trades

Insider Trading History

Track insider trading activity for Burrows Scott L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $28.1M 382,357 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$868k 12,500 shares
$69.42
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $7.2M 97,994 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$892k 12,500 shares
$71.37
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $8.12M 110,494 shares
Last Trade
May 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$868k 12,500 shares
$69.42
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $7.3M 99,294 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$370k 7,500 shares
$49.34
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $7.76M 105,494 shares
Last Trade
Apr 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$367k 7,500 shares
$48.90
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $29M 394,857 shares
Last Trade
Apr 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$367k 7,500 shares
$48.90
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $29.6M 402,357 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 2,500 shares
$40.07
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $7.39M 100,494 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$100k 2,500 shares
$40.07
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $7.22M 98,194 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$102k 2,500 shares
$40.65
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $10.3M 140,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.29M 140,000 shares
$30.61
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $7.2M 97,994 shares
Last Trade
Sep 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$300k 18,428 shares
$16.26
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $7.02M 95,500 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 95,500 shares
$21.66
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $8.56M 116,422 shares
Last Trade
Sep 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$522k 18,531 shares
$28.17
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $5.15M 70,000 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.81M 70,000 shares
$25.86
$73.52
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $9.92M 134,953 shares
Last Trade
Dec 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.45M 134,953 shares
$18.17
$73.52
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $1.62M 134,953 shares
Last Trade
Dec 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 134,953 shares
$12.01
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Financial Officer
Holding Value $122M 10,121,441 shares
Last Trade
Sep 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147M 10,121,441 shares
$14.50
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Financial Officer
Holding Value $744M 10,121,441 shares
Last Trade
Sep 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$73.52
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Chief Financial Officer
Holding Value $1.26M 59,115 shares
Last Trade
Mar 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.44k 291 shares
$15.26
$21.35
Arcutis Biotherapeutics
Arcutis Biotherapeutics ARQT
Chief Financial Officer
Holding Value $820k 38,424 shares
Last Trade
Mar 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.7k 1,434 shares
$15.83
$21.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up